$1.640
-0.224 (-13.68%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
Soll ich Exascale Labs Holdings Inc. Class A Common Stock-Aktien kaufen?
Given the current price of 2.04, the stock is trading significantly below its 52-week high of 7.39, indicating potential upside. The RSI is at 33.957, suggesting it is oversold, which could lead to a rebound. Additionally, the projected final change of +205.18% based on historical patterns indicates strong potential for recovery. However, the main risk is the significant 5-day change of -39.82%, reflecting recent volatility.
XLAB schloss am Thursday bei $1.64, nachdem der Kurs -13.68% fallen
Exascale Labs Holdings Inc. Class A Common Stock (XLAB) last closed at $1.64, losing -13.68%. These facts feed the 1-day and 1-week XLAB price prediction above.
Prognose-Treiber
Die Prognose-Treiber von Exascale Labs Holdings Inc. Class A Common Stock (XLAB) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Saisonalitätsanalyse für XLAB
Ähnliche Artikel
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.